WO1981002379A1 - Tobacco treatment - Google Patents

Tobacco treatment Download PDF

Info

Publication number
WO1981002379A1
WO1981002379A1 PCT/US1981/000198 US8100198W WO8102379A1 WO 1981002379 A1 WO1981002379 A1 WO 1981002379A1 US 8100198 W US8100198 W US 8100198W WO 8102379 A1 WO8102379 A1 WO 8102379A1
Authority
WO
WIPO (PCT)
Prior art keywords
tobacco
extract
potassium
denitrated
potassium nitrate
Prior art date
Application number
PCT/US1981/000198
Other languages
English (en)
French (fr)
Inventor
G Keritsis
Original Assignee
Philip Morris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Inc filed Critical Philip Morris Inc
Priority to BR8106869A priority Critical patent/BR8106869A/pt
Publication of WO1981002379A1 publication Critical patent/WO1981002379A1/en
Priority to DK453681A priority patent/DK155908C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts

Definitions

  • This invention relates to a method for maximizing reduction of delivery of nitrogen oxides, HCN and CO in tobacco smoke.
  • tobacco materials are contacted with an aqueous solution to form a tobacco extract.
  • the extract is treated to remove potassium nitrate.
  • potassium ions are restored to the tobacco extract to a level approximating that originally present in the unextracted tobacco.
  • Tobacco contains a number of nitrogen containing substances which during the burning of the tobacco yield various components in the smoke. Removal of some of these smoke components, such as the oxides of nitrogen, is considered desirable.
  • Nitrate salts such as potassium, calcium and magnesium nitrates, are a major class of nitrogenous substances which are precursors for nitrogen oxides, especially nitric oxide. These nitrate salts are normally found in great abundance in burley tobacco stems and strip, in flue-cured tobacco stems to a lesser degree, and in reconstituted tobaccos which utilize these components. Attempts have been made to reduce or remove the nitrate from these tobaccos to bring about a significant reduction in the oxides of nitrogen delivered in their smoke. Among the techniques which have been employed to this end are extraction methods whereby the nitrates are removed from the tobacco material.
  • tobacco materials are generally contacted with water.
  • an extract containing the tobacco solubles including the nitrates is formed.
  • the extract is collected and may be discarded or may be treated to remove the nitrates.
  • the denitrated extract may thereupon be reapplied to the fibrous insoluble tobacco material from which it was originally removed.
  • Patent 3,847, 164 den ⁇ tration is effected by means of ion- retardation resins which retard ionic material, specifically potassium nitrate, in tobacco extracts, while non-ionic constituents pass unaffected.
  • ion- retardation resins which retard ionic material, specifically potassium nitrate, in tobacco extracts, while non-ionic constituents pass unaffected.
  • U.S. Patent 3,616,801 describes a process for improving the tobacco burn properties, smoke flavor and ash by controlling the ion content of the tobacco.
  • the proportion of metallic ions in an aqueous tobacco extract is adjusted, followed by reapplication of the treated extract to the tobacco.
  • the treatments suggested for adjusting the metal ion content are ion exchange and membrane electrodialysis. Removal of potassium ions and their replacement with ammonium, hydrogen, calcium or magnesium ions are particularly desirable in the practice of this process. Levels of other ions including nitrate may also be adjusted to alter the tobacco properties. In Example 6, over 50% of both nitrate and potassium ions were removed by means of electrodialysis.
  • U.S. Patent 2,972,557 smoking tobacco is treated with an alkali metal compound such as sodium bicarbonate, potassium bicarbonate or potassium ruthenate at an approximate level of 2 to 8% to produce a smoking product which burns below a temperature of 800°F.
  • the temperature control substances reduce the amount of compounds that may be volatilized and released into the smoke.
  • U.S. Patent 3,126,01 1 there is disclosed a process for reducing high-molecular weight compounds resulting from pyrolysis of tobacco materials.
  • Incombustible solids capable of melting endothermically at a temperature at or below the burning temperature of the tobacco are suggested and include salts of borates, phosphates and silicates, and hydrates thereof with cations selected from potassium, lithium, and sodium.
  • the salts are applied to tobacco at a level between about 3 and 10% by weight.
  • tobacco is extensively extracted and the resultant extract discarded. No attempt is made to selectively remove certain constituents of the extract and then return the extract to the fibrous tobacco residue.
  • tobacco leaf ultimately used for cigar wrappers is subjected to a "steeping or scrubbing" action followed by further extraction in an aqueous-alkaline bath generally at a pH between 8 to 1 1.
  • the burning qualities of the tobacco are usually completely destroyed by the abovedescribed treatment.
  • a salt such as potassium acetate is added to the depleted fibrous tobacco residue by immersing the residue in an aqueous bath containing approximately 12.5 pounds potassium acetate per gallon of solution.
  • tobacco leaf is subjected to extraction in a nitric acid-containing bath whereby substantially all of the naturally occurring gums, oils, nicotine and mineral matter including salts are removed.
  • the "skeleton leaf” consisting essentially of the woody and starch components is then treated to impart the. desired color, flavor, aroma,' ash and smoking properties.
  • the process of the present invention is advantageous in that tobacco is subjected to aqueous extraction and the resultant extract is denitrated whereby potassium nitrate is predominantly removed while maintaining other desirable tobacco solubles intact. Thereafter potassium ions are restored to the potassium-depleted tobacco to a level approximating that originally present prior to extraction.
  • a proportionately greater reduction in delivery of nitrogen oxides in tobacco smoke relative to degree of nitrate removal is achieved than when the potassium ions are not restored.
  • the present invention provides a method for treating tobacco whereby a reduction of various gas phase components of tobacco smoke is achieved. Specifically, reduced NO, HCN and CO deliveries by tobacco smoke are effected. Moreover, the relative reduction of nitrogen oxide delivery by tobacco products during combustion is maximized.
  • tobacco materials are contacted with an aqueous solution to obtain an aqueous extract and an insoluble fibrous tobacco portion.
  • the extract and the insoluble fibrous materials are separated whereupon the extract is treated to remove potassium nitrate.
  • a potassium salt such as the citrate, acetate, mala-te, carbonate, bicarbonate or phosphate is restored to the thus treated potassium depleted extract to a level approximating the potassium ion content originally present in the tobacco.
  • the potassium enriched extract is then applied to the insoluble fibrous tobacco portion.
  • potassium ions in the form of potassium salts may be restored to the fibrous tobacco portion or may be incorporated at any stage of conventional tobacco processing. Smoking tobacco products containing tobacco which has been treated in this manner produce relatively less nitric oxide than products in which the potassium ions have not been restored.
  • tobacco is denitrated in a manner which enhances the relative reduction in delivery of oxides of nitrogen and reduces the delivery of HCN and CO. This is accomplished by removal of potassium nitrate salts followed by restoration of potassium ions in the form of salts other than potassium nitrate. By restoring the potassium ions to approximately the original level, a greater reduction in nitrogen oxide delivery, particularly nitric oxide, is achieved relative to the amount of nitrate removed, than when potassium is not restored.
  • the tobacco material is typically contacted with an aqueous solution in order to extract the soluble components, including potassium and nitrate salts.
  • the aqueous solution employed may be water or preferably a denitrated aqueous extract of tobacco containing tobacco solubles.
  • the extraction can be effected using 5: 1 to 100: 1 aqueous solution to tobacco ratio (w/w) at 20- 100°C, preferably 60-95°C, for a period of time ranging from a few seconds to several minutes or longer, depending on the particular temperature and volume of water or solubles used.
  • the wetted tobacco is generally pressed, centrifuged or filtered at the end of the extraction time whereby the excess water and residual nitrate that may be present on the tobacco surface and in suspension are removed.
  • the aqueous tobacco extract is then treated to remove the potassium nitrate contained therein while preferably minimizing the loss of other tobacco solubles.
  • the potassium nitrate may be removed by processes disclosed in U.S. Patents 4, 131 , 1 17 and 4, 131 , 1 18 wherein the tobacco extract is concentrated in vacuo to a total solids content of about 30% to 70% and a nitrate-nitrogen content of about 1 % to 3%.
  • the concentrated extract is then fed into a refrigerated centrifuge to effect crystallization of the potassium nitrate.
  • the crystalline salt is separated from the extract by filtration, centr ⁇ fugation or the like.
  • potassium in the form of a salt such as, for example, the citrate, acetate, malate, carbonate, bicarbonate or phosphate, is added to the denitrated tobacco extract, the fibrous portion or both in an amount sufficient to restore the potassium essentially to its original level prior to extraction.
  • the salt is preferably added as an aqueous spray but may be applied in any manner in which an even distribution on the tobacco is obtained.
  • the potassium salt may be added after extraction and before drying, or it may be incorporated in casing solutions and applied to the tobacco at any stage during conventional processing.
  • the restoration of potassium ions to the extracted tobacco results in reduced levels of oxides of nitrogen, carbon monoxide and HCN when compared to extracted tobacco that has not been treated to restore the potassium ions.
  • the amount of potassium salts present in tobacco will vary depending on the type of tobacco being treated. For example, burley tobaccos generally will have a higher content of potassium salts than bright tobacco. Crop variation due to seasonal factors may also influence the amount of potassium salts present in tobacco. In order to determine the amount of potassium ions lost during denitration wherein potassium nitrate is predominantly removed, it is only necessary to measure the potassium level prior to and after denitration of the tobacco. Potassium determinations may be made by extracting a small sample of tobacco with dilute acid and analyzing an aliquot of the extract by conventional atomic absorption spectrophotometry. Details of the procedure used for measuring potassium levels may be found in Analytical Methods of Analysis by Atomic Absorption Spectrophotometry published by Perkin Elmer, September 1976.
  • a partially denitrated tobacco extract prepared according to the process previously described in U.S. Patents 4, 131 , 1 17 and 4,131 , 1 18, the contents of which are incorporated herein by reference, may be further denitrated, for example, by ionic membrane electrodialysis.
  • the tobacco extract may be denitrated by electrodialysis without prior treatment via the crystallization process.
  • a tobacco extract whether partially denitrated or not is adjusted to a solids content of about 5-50% and a resistivity of about 8-50 ohm-cm and is then rapidly circulated through the alternate cells of an electrodialysis unit.
  • the unit comprises an anion permeable membrane toward the anode spaced no more than about 0.04 inches from an anion impermeable membrane toward the cathode. Brine is circulated in the remaining cells and voltage of about 0.5 to about 2.0 volts/cell pair is applied thereby selectively extracting the nitrate salts into the brine cells, without substantial removal of other tobacco solubles.
  • the anions present in the tobacco extract cells migrate toward the anode upon imposition of an electric potential.
  • the brine cells into which the nitrate ions migrate have an anion impermeable membrane toward the anode; therefore, the nitrate ions remain and are concentrated in the brine cells and can thus be removed from the system.
  • Potassium ions migrate in a similar manner toward the cathode upon imposition of an electrical potential.
  • the electrodes employed in the electrodialysis unit may be carbon, stainless steel, platinum, or other type of non-corrosive conductive material that does not react with the electrolyte . and does not introduce metallic ions in solution, especially polyvalent ions such as Cu ++ and Al +++ , that may react with the ionic membrane or with the tobacco solubles and cause membrane fouling and/or scaling on the membrane surface.
  • metallic ions especially polyvalent ions such as Cu ++ and Al +++ , that may react with the ionic membrane or with the tobacco solubles and cause membrane fouling and/or scaling on the membrane surface.
  • hastelloy carbon cathode plates and platinized columbium anode plates are employed.
  • the solutions in the electrode cells may be different for the anode and the cathode, but preferably are the same.
  • These electrolyte solutions should comprise an approximately 0. I N solution of an alkali metal salt, preferably a potassium salt of an anion that will not react and will create minimum gas at the electrodes or of an anion that will not foul the membranes nor precipitate polyvalent cations such as Ca ++ , Mg ++ , Al +++ , and the like on the surface of the membrane.
  • an alkali metal salt preferably a potassium salt of an anion that will not react and will create minimum gas at the electrodes or of an anion that will not foul the membranes nor precipitate polyvalent cations such as Ca ++ , Mg ++ , Al +++ , and the like on the surface of the membrane.
  • Electrolytes that are particularly preferred are those containing potassium acetate or sulfate and having a pH of about 2-5.
  • the membranes employed to isolate the electrodes may be of the same nature and thickness as those used in the overall stack. However, these membranes are preferably thicker, more ionic and tighter (less porous). Also, the spacers that are placed between the electrodes and the anode-cathode membranes may be of the same thickness as those used in the overall stack, but preferably they should be thicker, i.e., about twice the thickness of the remaining spacers to allow a greater circulation ratio of electrolyte on the surface of the electrodes.
  • the brine solution will typically be aqueous. It is preferable that a small concentration of ionic material be present in the brine during the initial phase of operation in order to create some conductivity.
  • the brine may initially be seeded to 0.1 weight percent potassium or sodium nitrate, chloride or acetate, or nitric, hydrochloric, or acetic acid or with potassium or sodium hydroxide.
  • the anion permeable membranes may be neutral or ionic membranes having a positive fixed electrical charge. Positively charged membranes which will attract and pass anions and repel cations are anion permeable. Cation permeable membranes are negatively charged and will attract and pass cations and repel anions. Neutral membranes will alloweither anions or cations to pass through when a voltage is applied across the ionic solution that is confined between such membranes. The use of electrodialysis will be described in greater detail In the examples hereinbelow.
  • the efficiency of the process is enhanced in a system using ion exchange resins and membrane electrodialysis.
  • electro-regenerated ion exchange deionization the setup is the same as membrane electrodialysis except for the addition of a mixed bed of weak ion exchange or ionic resins to each cell through which the tobacco solubles are to be passed.
  • the dilute solution of ions to be deionized enters the cells that contain the mixed bed of resins.
  • the ions are "trapped" or picked up by the resins causing an increase in ionic concentration and electroconductivity between the electrodes of the electrodialysis cell and thus a lesser amount of electrical power is required.
  • the applied electrical potential causes the anions to transfer through their respective membranes into the brine cells where they are concentrated and removed.
  • the mixed bed of the weak ion exchange resins is continuously regenerated without interruption and without the use of high amounts of additional chemicals or additional power as is the case with standard ion exchangers.
  • the mixed bed of weak ion exchange resins may be composed of a single resin having both negative and positive groups, two different resins, one anionic and one cationic, in bed or "spacer" type form.
  • the spacer form may be in a basket or wire cloth type weave or in film form (similar to bipolar membranes) specially manifolded to allow flow.
  • Another method of removing potassium nitrate in accordance with the invention entails the use of ion exchange or ion retardation techniques.
  • the tobacco extract, in either dilute or concentrated form is passed over a mixed bed of anion and cation exchange resins whereby the potassium nitrate is removed.
  • the tobacco extract having a solids concentration of 3% to 30% is passed over a mixed bed or column of anion/cation exchange resins such as Rexyn 101 (H) which is a sulfonated polystyrene-divinyl benzene copolymer having active groups (cation exchange) and Rexyn 201 (OH) which is a polystyrene-divinyl benzene alkyI quaternary amine having R 4 N + active group (anion exchange). Denitration may also be effected by means of Donnan dialysis.
  • a cationic membrane (positively charged, anion permeable) is utilized to separate the tobacco extract from the stripping solution.
  • the stripping solution will be a preferably strong base, such as sodium or potassium hydroxide at a pH of 7.5 to 9.5.
  • the time required to denitrate the tobacco extract depends on the membrane surface, the thickness of the membrane and the tobacco extract compartment as well as the nitrate concentration and temperature used. Materials such as metaphosphates may be added to the tobacco extract or stripping media to maintain polyvalent metal ions in solution and prevent their precipitation on the membrane surface.
  • extraction of the tobacco material may be effected with denitrated tobacco extracts.
  • this expedient it is possible to reduce the amount of non-nitrate materials removed from the tobacco since after several extractions the extract liquor will approach saturation. Thus, except for the nitrates, reduced amounts of materials will be removed during subsequent extraction steps. This is a preferred mode of operation for treating tobacco strip or reconstituted tobacco.
  • Potassium restoration is accomplished by adding to the denitrated extract or fibrous tobacco portion a suitable potassium salt such as the citrate, acetate, malate, carbonate, bicarbonate or phosphate, generally in an aqueous solution.
  • a suitable potassium salt such as the citrate, acetate, malate, carbonate, bicarbonate or phosphate, generally in an aqueous solution.
  • the restoration may be carried out by spraying, dipping and the like.
  • the extract Prior to reapplication the extract may be concentrated if necessary or desired.
  • the reapplication may be effected by any suitable means such as spraying, coating, dipping or slurry processes.
  • the tobacco may then be dried or otherwise processed to put it in condition for use in tobacco products.
  • treated tobacco may be used in any smoking tobacco product desired.
  • the tobacco products will exhibit reduced delivery of nitrogen oxides, HCN and CO during combustion. Further, the ratio of nitrogen oxide reduction to nitrate removed for products formed from tobacco treated in accordance with the invention is greater than that for products containing tobacco which has not been selectively denitrated.
  • references to tobacco and tobacco materials include all such forms of tobacco.
  • the tobacco treated in accordance with the invention reduces nitrogen oxide delivery in any tobacco product which is consumed by combustion and that references to smoking tobacco products include cigars, cigarettes, cigariIlos, pipe tobacco and the like.
  • the following examples are illustrative:
  • Example I Bur ley tobacco was extracted with water and portions of the extract were subjected to ion exchange treatments. One portion was treated with Fisher Scientific Rexyn 201 (OH) anion exchange resin, which is a polystyrene-divinyl benzene alkyl quaternary amine having R 4 N + active groups, to selectively remove nitrate ions without removing potassium ions.
  • Fisher Scientific Rexyn 201 (OH) anion exchange resin which is a polystyrene-divinyl benzene alkyl quaternary amine having R 4 N + active groups, to selectively remove nitrate ions without removing potassium ions.
  • a second portion of the tobacco solubles was treated with a mixed bed of exchange resins composed of the above Fisher Scientific Rexyn 201 (OH) resin and a Fisher Scientific Rexyn 101 (H) cation exchange resin, which is a sulfonated polystyrene-divinyl benzene copolymer having RSOZ active groups, to effect removal of both potassium and nitrate ions.
  • the composition of the extract and the gas phase delivery of the tobacco upon recombination with the extracts were analyzed. Similar analyses were conducted on unextracted burley tobacco, burley tobacco extracted with water and burley tobacco extracted with water and cased with potassium citrate.
  • Tobacco was pulped with water and the extract containing the solubles was separated and concentrated.
  • the extract was partially denitrated in accordance with the crystallization methods of U.S. Patents 4, 131 ,1 17 and 4, 131 , 1 18.
  • a portion of the resulting extract was thereupon further denitrated by electrodialysis employing a 20 cell pair unit.
  • the membranes were 9" x 10" with an effective membrane area of 5.0 ft 2 .
  • the cells comprised Ionics' 6 ICZL 386 cation permeable paired with I03QZL 386 anion permeable membranes.
  • anion permeable membranes are about 0.63 mm thick, contain about 36 weight percent water and comprise crosslinked copolymers of vinyl monomers and contain quarternary ammonium anion exchange groups and are homogeneously film cast in sheet form on a reinforcing synthetic fabric composed of modacryiic polymer.
  • the cation permeable membranes are about 0.6 mm thick, contain about 40 weight percent water and comprise crosslinked sulfonated copolymers of vinyl compounds which are also homogeneously film cast in sheet form on synthetic reinforcing fabrics.
  • the spacers were 0.04".
  • the membranes in front of the electrodes were Ionics' 6 IAZL-389 which were separated from the platinum-niobium, stainless steel electrodes by 0.08" thick spacers.
  • the brine solutions were 0.1 % aqueous KNO 3 solutions, and the electrolytes were 0. IN K 2 SO 4 and H 2 SO 4 having a pH adjusted to 2 to 4.
  • the electrodialysis was effected by application of 30 volts.
  • the temperature of the solubles during the runs were not controlled and varied between about 88-98°C.
  • the pH at 22°C was about 4.75.
  • Half of the resulting denitrated extract was thereupon reapplied to a portion of the tobacco web formed from the extracted pulp and used to form sample cigarettes.
  • a second sample was prepared by adding potassium acetate to the remaining electrodialyzed solubles prior to reapplication to the web.
  • the control sample comprised web treated with the partially denitrated extract.
  • Example 3 Three kg of burley strip was extracted with 26 liters of water at 80°C. The tobacco was dipped in the water bath for a contact time of 1 minute. The extracted tobacco was dried, equilibrated, shredded, and made into cigarettes having conventional cellulose acetate filters attached thereto. Unextracted burley tobacco was also shredded and used for control cigarettes. A second batch of identical burley strip was extracted in the same manner and then dried and equilibrated. Potassium content of the extracted tobacco was measured and potassium citrate was applied to the dried tobacco to a level approximating that originally present.
  • the data indicate that improved reductions are achieved in such gas phase smoke components as NO, HCN and to a lesser extent CO, when potassium is restored to tobaccos which have been treated to remove potassium nitrate.
  • the data also indicate that potassium restoration does not alter the puff count.
  • burley strip tobacco Thirty parts of burley strip tobacco were extracted with 450 parts of water at 90°C. The fibrous tobacco portion was separated from the aqueous portion by centrifugation and air dried at room temperature.
  • the aqueous extract was treated with a mixed anion-cation exchange resin [Fisher Scientific Rexyn 201 (OH) and Rexyn 101 (H)] to remove both potassium and nitrate ions. Thereafter the denitrated extract was concentrated to a solids content of approximately 15%.
  • a mixed anion-cation exchange resin [Fisher Scientific Rexyn 201 (OH) and Rexyn 101 (H)]
  • the concentrated extract was divided into three equal weight portions and reapplied to equal weight portions of the fibrous tobacco residue to produce three sheets of reconstituted tobacco in the following manner:
  • Sheet A Extract plus residue
  • Sheet B Extract plus residue plus potassium citrate in an amount sufficient to give a 2% by weight restoration of potassium to the final sheet;
  • Sheet C Same as B except that the restoration of potassium in the form of potassium citrate was 4% by weight.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Extraction Or Liquid Replacement (AREA)
PCT/US1981/000198 1980-02-21 1981-02-18 Tobacco treatment WO1981002379A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR8106869A BR8106869A (pt) 1980-02-21 1981-02-18 Travamento de tabaco
DK453681A DK155908C (da) 1980-02-21 1981-10-13 Fremgangsmaade til behandling af tobak til nedsaettelse af afgivelse af gasfasekomponenter under forbraendingen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/123,247 US4589428A (en) 1980-02-21 1980-02-21 Tobacco treatment
US123247 1980-02-21

Publications (1)

Publication Number Publication Date
WO1981002379A1 true WO1981002379A1 (en) 1981-09-03

Family

ID=22407547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1981/000198 WO1981002379A1 (en) 1980-02-21 1981-02-18 Tobacco treatment

Country Status (14)

Country Link
US (1) US4589428A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0034922B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0112470B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR228269A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU540521B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR8106869A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1153543A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3170572D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK155908C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES499624A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR74120B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH20375A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1178311A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1981002379A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (169)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3439900A1 (de) * 1984-10-31 1986-04-30 Alexei 8000 München Filippenko Tabakfeinschnitt
US5040551A (en) * 1988-11-01 1991-08-20 Catalytica, Inc. Optimizing the oxidation of carbon monoxide
US5211684A (en) * 1989-01-10 1993-05-18 R. J. Reynolds Tobacco Company Catalyst containing smoking articles for reducing carbon monoxide
HRP940578B1 (en) * 1993-10-07 1999-10-31 Hans Noe Rod-shaped smoking article
US5435941A (en) * 1993-12-17 1995-07-25 University Of Louisville Tobacco extract composition and method
US6772767B2 (en) * 2002-09-09 2004-08-10 Brown & Williamson Tobacco Corporation Process for reducing nitrogen containing compounds and lignin in tobacco
JP4159395B2 (ja) * 2003-04-11 2008-10-01 カゴメ株式会社 野菜汁からの硝酸性窒素の除去方法
KR100730631B1 (ko) * 2003-05-06 2007-06-20 니뽄 다바코 산교 가부시키가이샤 재생 담배재의 제조방법
CN2719043Y (zh) 2004-04-14 2005-08-24 韩力 雾化电子烟
ATE553074T1 (de) * 2004-05-24 2012-04-15 British American Tobacco Co Molekular geprägte, nitrosaminselektive polymere und verfahren zu deren anwendung
US20050263161A1 (en) * 2004-05-27 2005-12-01 Brown & Williamson Tobacco Corporation Tobacco filler of low nitrogen content
WO2006022198A1 (ja) * 2004-08-24 2006-03-02 Japan Tobacco Inc. マグネシウムイオンを除去するためのタバコ抽出液の処理方法、再生タバコ材の製造方法、および再生タバコ材
US7726320B2 (en) 2006-10-18 2010-06-01 R. J. Reynolds Tobacco Company Tobacco-containing smoking article
US20080167599A1 (en) 2007-01-10 2008-07-10 The Procter & Gamble Comapny Active applicator
US20130014771A1 (en) 2011-01-13 2013-01-17 R. J. Reynolds Tobacco Company Tobacco-derived components and materials
US8955523B2 (en) 2010-01-15 2015-02-17 R.J. Reynolds Tobacco Company Tobacco-derived components and materials
US9039839B2 (en) 2010-04-08 2015-05-26 R.J. Reynolds Tobacco Company Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material
US9402415B2 (en) 2010-04-21 2016-08-02 R. J. Reynolds Tobacco Company Tobacco seed-derived components and materials
US11344683B2 (en) 2010-05-15 2022-05-31 Rai Strategic Holdings, Inc. Vaporizer related systems, methods, and apparatus
US8757147B2 (en) 2010-05-15 2014-06-24 Minusa Holdings Llc Personal vaporizing inhaler with internal light source
US9155321B2 (en) 2010-08-11 2015-10-13 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US9675102B2 (en) 2010-09-07 2017-06-13 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
US20120125354A1 (en) * 2010-11-18 2012-05-24 R.J. Reynolds Tobacco Company Fire-Cured Tobacco Extract and Tobacco Products Made Therefrom
US9775376B2 (en) 2010-12-01 2017-10-03 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
US9220295B2 (en) * 2010-12-01 2015-12-29 R.J. Reynolds Tobacco Company Tobacco separation process for extracting tobacco-derived materials, and associated extraction systems
US9204667B2 (en) 2010-12-01 2015-12-08 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
US20120152265A1 (en) 2010-12-17 2012-06-21 R.J. Reynolds Tobacco Company Tobacco-Derived Syrup Composition
US8893725B2 (en) 2011-01-28 2014-11-25 R. J. Reynolds Tobacco Company Polymeric materials derived from tobacco
US9458476B2 (en) 2011-04-18 2016-10-04 R.J. Reynolds Tobacco Company Method for producing glycerin from tobacco
US9254001B2 (en) 2011-04-27 2016-02-09 R.J. Reynolds Tobacco Company Tobacco-derived components and materials
RU2454161C1 (ru) * 2011-05-05 2012-06-27 Олег Иванович Квасенков Способ производства некурительного изделия из табака
RU2454148C1 (ru) * 2011-05-05 2012-06-27 Олег Иванович Квасенков Способ производства некурительного изделия из табака
RU2454150C1 (ru) * 2011-05-11 2012-06-27 Олег Иванович Квасенков Способ получения некурительного изделия из табака
RU2454159C1 (ru) * 2011-05-11 2012-06-27 Олег Иванович Квасенков Способ получения некурительного изделия из табака
RU2454154C1 (ru) * 2011-05-11 2012-06-27 Олег Иванович Квасенков Способ получения некурительного изделия из табака
RU2454157C1 (ru) * 2011-05-11 2012-06-27 Олег Иванович Квасенков Способ получения некурительного изделия из табака
RU2454149C1 (ru) * 2011-05-11 2012-06-27 Олег Иванович Квасенков Способ получения некурительного изделия из табака
US9192193B2 (en) 2011-05-19 2015-11-24 R.J. Reynolds Tobacco Company Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles
US9078473B2 (en) 2011-08-09 2015-07-14 R.J. Reynolds Tobacco Company Smoking articles and use thereof for yielding inhalation materials
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130118512A1 (en) 2011-11-16 2013-05-16 R.J. Reynolds Tobacco Company Smokeless tobacco products with starch component
US20130125907A1 (en) 2011-11-17 2013-05-23 Michael Francis Dube Method for Producing Triethyl Citrate from Tobacco
US20130125904A1 (en) 2011-11-18 2013-05-23 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising pectin component
US10881132B2 (en) 2011-12-14 2021-01-05 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US12285025B2 (en) 2012-02-10 2025-04-29 R.J. Reynolds Tobacco Company Multi-layer smokeless tobacco composition
US9420825B2 (en) 2012-02-13 2016-08-23 R.J. Reynolds Tobacco Company Whitened tobacco composition
WO2013142483A1 (en) 2012-03-19 2013-09-26 R. J. Reynolds Tobacco Company Method for treating an extracted tobacco pulp and tobacco products made therefrom
US20130269719A1 (en) 2012-04-11 2013-10-17 R.J. Reynolds Tobacco Company Method for treating plants with probiotics
US9339058B2 (en) 2012-04-19 2016-05-17 R. J. Reynolds Tobacco Company Method for producing microcrystalline cellulose from tobacco and related tobacco product
US9485953B2 (en) 2012-07-19 2016-11-08 R.J. Reynolds Tobacco Company Method for treating tobacco plants with enzymes
US9289011B2 (en) 2013-03-07 2016-03-22 R.J. Reynolds Tobacco Company Method for producing lutein from tobacco
US9155334B2 (en) 2013-04-05 2015-10-13 R.J. Reynolds Tobacco Company Modification of bacterial profile of tobacco
US20150034109A1 (en) 2013-08-02 2015-02-05 R.J. Reynolds Tobacco Company Process for Producing Lignin from Tobacco
US11503853B2 (en) 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
US9265284B2 (en) 2014-01-17 2016-02-23 R.J. Reynolds Tobacco Company Process for producing flavorants and related materials
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US9839238B2 (en) 2014-02-28 2017-12-12 Rai Strategic Holdings, Inc. Control body for an electronic smoking article
US10111458B1 (en) 2014-05-16 2018-10-30 R.J. Reynolds Tobacco Company Process for inhibiting formation of nitrosamines
US10881133B2 (en) 2015-04-16 2021-01-05 R.J. Reynolds Tobacco Company Tobacco-derived cellulosic sugar
US20170059554A1 (en) 2015-09-02 2017-03-02 R. J. Reynolds Tobacco Company Method for monitoring use of a tobacco product
US10869497B2 (en) 2015-09-08 2020-12-22 R.J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
US10034494B2 (en) 2015-09-15 2018-07-31 Rai Strategic Holdings, Inc. Reservoir for aerosol delivery devices
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US11612183B2 (en) 2015-12-10 2023-03-28 R.J. Reynolds Tobacco Company Protein-enriched tobacco composition
US10499684B2 (en) 2016-01-28 2019-12-10 R.J. Reynolds Tobacco Company Tobacco-derived flavorants
US11154087B2 (en) 2016-02-02 2021-10-26 R.J. Reynolds Tobacco Company Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds
US10721957B2 (en) 2016-10-04 2020-07-28 R.J. Reynolds Tobacco Company Tobacco-derived colorants and colored substrates
US10813383B2 (en) 2016-12-12 2020-10-27 R.J. Reynolds Tobacco Company Dehydration of tobacco and tobacco-derived materials
US11091446B2 (en) 2017-03-24 2021-08-17 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines
US10470487B2 (en) 2017-04-06 2019-11-12 R.J. Reynolds Tobacco Company Smoke treatment
US10757964B2 (en) 2017-07-20 2020-09-01 R.J. Reynolds Tobacco Company Purification of tobacco-derived protein compositions
US11278050B2 (en) 2017-10-20 2022-03-22 R.J. Reynolds Tobacco Company Methods for treating tobacco and tobacco-derived materials to reduce nitrosamines
US20190307082A1 (en) 2018-04-05 2019-10-10 R.J. Reynolds Tobacco Company Oriental tobacco production methods
US20200196658A1 (en) 2018-12-20 2020-06-25 R.J. Reynolds Tobacco Company Method for whitening tobacco
US11523623B2 (en) 2019-01-18 2022-12-13 R.J. Reynolds Tobacco Company Plant-derived protein purification
US12213510B2 (en) 2019-09-11 2025-02-04 Nicoventures Trading Limited Pouched products with enhanced flavor stability
US12063953B2 (en) 2019-09-11 2024-08-20 Nicoventures Trading Limited Method for whitening tobacco
JP2022547977A (ja) 2019-09-11 2022-11-16 ニコベンチャーズ トレーディング リミテッド タバコを白色化するための代替方法
US12342847B2 (en) 2019-09-11 2025-07-01 Nicoventures Trading Limited Oral product with cellulosic flavor stabilizer
US11369131B2 (en) 2019-09-13 2022-06-28 Nicoventures Trading Limited Method for whitening tobacco
US11903406B2 (en) 2019-09-18 2024-02-20 American Snuff Company, Llc Method for fermenting tobacco
CN110693065B (zh) * 2019-09-20 2022-07-01 云南中烟工业有限责任公司 一种在线控制电渗析处理烟梗提取液离子脱除程度的方法
MX2022005285A (es) 2019-10-31 2022-05-24 Nicoventures Trading Ltd Producto oral y metodo de fabricacion.
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
WO2021116895A2 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Stimulus-responsive pouch
WO2021116865A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Agents for oral composition
WO2021116855A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions and methods of manufacture
US20210169788A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral product and method of manufacture
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US20210169890A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition with polymeric component
US20210169137A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Pouched products
WO2021116856A2 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products
US20210169129A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Lipid-containing oral composition
WO2021116842A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with controlled release
WO2021116919A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Fleece for oral product with releasable component
US20210169123A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Pouched products with enhanced flavor stability
US12151023B2 (en) 2019-12-09 2024-11-26 Nicoventures Trading Limited Oral composition with beet material
JP2023504916A (ja) 2019-12-09 2023-02-07 ニコベンチャーズ トレーディング リミテッド ヒートシール可能な結合剤を有するパウチ製品
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
PH12022551272A1 (en) 2019-12-09 2023-11-29 Nicoventures Trading Ltd Oral product with dissolvable component
US20210169121A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Liquid oral composition
JP2023505798A (ja) 2019-12-09 2023-02-13 ニコベンチャーズ トレーディング リミテッド パウチ製品のための積層フリース
US20210169126A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition with salt inclusion
EP4549642A3 (en) 2019-12-09 2025-07-02 Nicoventures Trading Limited Fleece for oral product with releasable component
US20210169783A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral products with controlled release
US20210169132A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition including gels
US20210169785A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral compositions with reduced water activity
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
WO2021116881A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product in a pourous pouch comprising a fleece material
US20210169138A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Fibrous fleece material
MX2022007085A (es) 2019-12-09 2022-08-19 Nicoventures Trading Ltd Nanoemulsion para uso oral.
WO2021116916A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product with multiple flavors having different release profiles
US20210170031A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
CA3160269A1 (en) 2019-12-09 2021-06-17 Christopher Keller Oral products
US11672862B2 (en) 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US20210169784A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Buffered oral compositions
US20210195938A1 (en) 2019-12-27 2021-07-01 Nicoventures Trading Limited Substrate with multiple aerosol forming materials for aerosol delivery device
US12016369B2 (en) 2020-04-14 2024-06-25 Nicoventures Trading Limited Regenerated cellulose substrate for aerosol delivery device
WO2021250516A1 (en) 2020-06-08 2021-12-16 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
US11937626B2 (en) 2020-09-04 2024-03-26 Nicoventures Trading Limited Method for whitening tobacco
US20220104532A1 (en) 2020-10-07 2022-04-07 NIlCOVENTURES TRADING LIMITED Methods of making tobacco-free substrates for aerosol delivery devices
US20240008522A1 (en) 2020-11-18 2024-01-11 Nicoventures Trading Limited Oral products
EP4284972A1 (en) 2021-01-28 2023-12-06 Nicoventures Trading Limited Method for sealing pouches
KR20230159852A (ko) 2021-03-19 2023-11-22 니코벤처스 트레이딩 리미티드 에어로졸 전달 장치를 위한 비드-포함 기재
JP2024510316A (ja) 2021-03-19 2024-03-06 ニコベンチャーズ トレーディング リミテッド エアロゾルデリバリーデバイスのための押出成形された基材
MX2023012537A (es) 2021-04-22 2024-01-24 Nicoventures Trading Ltd Composiciónes orales y metodos de fabricacion.
JP2024516807A (ja) 2021-04-22 2024-04-17 ニコベンチャーズ トレーディング リミテッド 口腔で溶解するフィルム
US20220354785A1 (en) 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
MX2023012535A (es) 2021-04-22 2024-01-24 Nicoventures Trading Ltd Composicion oral efervescente.
US20220354156A1 (en) 2021-04-30 2022-11-10 Nicoventures Trading Limited Oral pouched product with high density load
US20220354155A1 (en) 2021-04-30 2022-11-10 Nicoventures Trading Limited Multi-compartment oral pouched product
EP4333650A1 (en) 2021-05-06 2024-03-13 Nicoventures Trading Limited Oral compositions and related methods for reducing throat irritation
WO2022264066A1 (en) 2021-06-16 2022-12-22 Nicoventures Trading Limited Pouched product comprising dissolvable composition
EP4358747A1 (en) 2021-06-21 2024-05-01 Nicoventures Trading Limited Oral product tablet and method of manufacture
WO2022269556A1 (en) 2021-06-25 2022-12-29 Nicoventures Trading Limited Oral products and method of manufacture
CA3224138A1 (en) 2021-06-30 2023-01-05 Nicoventures Trading Limited Substrate with multiple aerosol forming materials for aerosol delivery device
EP4376642A1 (en) 2021-07-30 2024-06-05 Nicoventures Trading Limited Aerosol generating substrate comprising microcrystalline cellulose
CA3233375A1 (en) 2021-09-30 2023-04-06 Michael Zawadzki Oral product with a basic amine and an ion pairing agent
JP2024537801A (ja) 2021-09-30 2024-10-16 ニコベンチャーズ トレーディング リミテッド 口腔用ガム組成物
MX2024005869A (es) 2021-11-15 2024-07-15 Nicoventures Trading Ltd Productos con caracteristicas sensoriales mejoradas.
US20230189877A1 (en) 2021-12-20 2023-06-22 Nicoventures Trading Limited Substrate material comprising beads for aerosol delivery devices
US20230309603A1 (en) 2022-03-31 2023-10-05 R.J. Reynolds Tobacco Company Agglomerated botanical material for oral products
WO2023194959A1 (en) 2022-04-06 2023-10-12 Nicoventures Trading Limited Pouched products with heat sealable binder
WO2024069544A1 (en) 2022-09-30 2024-04-04 Nicoventures Trading Limited Reconstituted tobacco substrate for aerosol delivery device
WO2024069542A1 (en) 2022-09-30 2024-04-04 R. J. Reynolds Tobacco Company Method for forming reconstituted tobacco
EP4601490A1 (en) 2022-10-14 2025-08-20 Nicoventures Trading Limited Capsule-containing pouched products
WO2024089588A1 (en) 2022-10-24 2024-05-02 Nicoventures Trading Limited Shaped pouched products
EP4611563A1 (en) 2022-11-01 2025-09-10 Nicoventures Trading Limited Method of preparing a pouched product comprising a nicotine salt
EP4611565A1 (en) 2022-11-01 2025-09-10 Nicoventures Trading Limited Products with spherical filler
WO2024161256A1 (en) 2023-01-31 2024-08-08 Nicoventures Trading Limited Aerosol generating materials including a botanical material
WO2024161353A1 (en) 2023-02-02 2024-08-08 Nicoventures Trading Limited Capsule-containing aerosol-generating substrate for aerosol delivery device
WO2024171117A1 (en) 2023-02-15 2024-08-22 Nicoventures Trading Limited Oral products with high-density load
WO2024171119A1 (en) 2023-02-17 2024-08-22 Nicoventures Trading Limited Fibrous material for aerosol delivery device
WO2024180481A1 (en) 2023-02-28 2024-09-06 Nicoventures Trading Limited Caffeine-containing oral product
WO2024201300A1 (en) 2023-03-30 2024-10-03 Rai Strategic Holdings, Inc. Aerosol precursor composition comprising monomenthyl ester
WO2024252653A1 (ja) * 2023-06-09 2024-12-12 日本たばこ産業株式会社 たばこ材料、製造方法、および喫煙物品
WO2025068817A1 (en) 2023-09-29 2025-04-03 R. J. Reynolds Tobacco Company Apparatus and system for recovering material from oral wrapped products and related method
GB202319627D0 (en) 2023-12-20 2024-01-31 Nicoventures Trading Ltd Diffusion-modifying pouch for oral products
GB202319621D0 (en) 2023-12-20 2024-01-31 Nicoventures Trading Ltd Oral product comprising porous sponge
EP4585055A1 (en) 2024-01-12 2025-07-16 Nicoventures Trading Limited Oral product with probiotic component
EP4595781A1 (en) 2024-01-31 2025-08-06 Nicoventures Trading Limited Pouched products containing shreddable filler
EP4599698A1 (en) 2024-02-07 2025-08-13 Nicoventures Trading Limited Products comprising sensory agents
EP4602929A1 (en) 2024-02-19 2025-08-20 Nicoventures Trading Limited Oral product with powder coating

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3616801A (en) * 1968-10-28 1971-11-02 Philip Morris Inc Process for the treatment of tobacco to effect ion removal
US3847164A (en) * 1973-10-11 1974-11-12 Kimberly Clark Co Method of making reconstituted tobacco having reduced nitrates
US4131118A (en) * 1976-11-12 1978-12-26 Philip Morris Incorporated Method for removal of potassium nitrate from tobacco extracts

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126011A (en) * 1964-03-24 Tobacco composition and smoking unit
US467055A (en) * 1892-01-12 Cured tobacco
US2029494A (en) * 1933-02-13 1936-02-04 Fed Tobacco Corp Treatment of tobacco
US2122421A (en) * 1937-07-30 1938-07-05 Du Pont Tobacco treatment
US2776916A (en) * 1954-08-23 1957-01-08 Ralph L Ericsson Tobacco composition
US2914072A (en) * 1955-01-31 1959-11-24 Tyrer Daniel Process of improving the smoking qualities of tobacco
US3385303A (en) * 1966-06-16 1968-05-28 Philip Morris Inc Reconstituted tobacco product
DE2632693A1 (de) * 1976-07-21 1978-02-02 Bat Cigarettenfab Gmbh Tabak, dessen rauch arm an kondensierenden bestandteilen und aldehyden ist, und verfahren zu seiner herstellung
US4131117A (en) * 1976-12-21 1978-12-26 Philip Morris Incorporated Method for removal of potassium nitrate from tobacco extracts
EP0005082B1 (en) * 1978-04-25 1982-05-12 Philip Morris Incorporated Microbial nitrate removal from tobacco materials by dissimilatory denitrification

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3616801A (en) * 1968-10-28 1971-11-02 Philip Morris Inc Process for the treatment of tobacco to effect ion removal
US3847164A (en) * 1973-10-11 1974-11-12 Kimberly Clark Co Method of making reconstituted tobacco having reduced nitrates
US4131118A (en) * 1976-11-12 1978-12-26 Philip Morris Incorporated Method for removal of potassium nitrate from tobacco extracts

Also Published As

Publication number Publication date
DE3170572D1 (en) 1985-06-27
PH20375A (en) 1986-12-08
AU6751881A (en) 1981-08-27
US4589428A (en) 1986-05-20
JPS57500182A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-02-04
AU540521B2 (en) 1984-11-22
DK453681A (da) 1981-10-13
DK155908C (da) 1989-10-23
EP0034922A1 (en) 1981-09-02
DK155908B (da) 1989-06-05
EP0034922B1 (en) 1985-05-22
JPH0112470B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-03-01
CA1153543A (en) 1983-09-13
AR228269A1 (es) 1983-02-15
ES8205542A1 (es) 1982-07-01
ES499624A0 (es) 1982-07-01
BR8106869A (pt) 1981-12-22
SU1178311A3 (ru) 1985-09-07
GR74120B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-06-06

Similar Documents

Publication Publication Date Title
US4589428A (en) Tobacco treatment
US4253929A (en) Method for denitration of tobacco employing electrodialysis
US4301817A (en) Method for selective denitration of tobacco
US4364401A (en) Method for selective denitration of tobacco
US3616801A (en) Process for the treatment of tobacco to effect ion removal
US4215706A (en) Nicotine transfer process
US3385303A (en) Reconstituted tobacco product
US5339838A (en) Method for providing a reconstituted tobacco material
US4964426A (en) Tobacco smoke filters and process for production thereof
US4302308A (en) Method for electrolytic denitration of tobacco
CH631330A5 (de) Verfahren zur herstellung von synthetischen rauchmaterialien.
EP1545249A1 (en) A process for reducing nitrogen containing compounds and lignin in tobacco
US4296762A (en) Smokable products
NO131152B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US3380458A (en) Method for producing a cigarette with low tar yield
US5150723A (en) Process for the production of tobacco smoke filters
US3874390A (en) Smokable products based on carbonized filler-containing cellulose films
US3106211A (en) Tobacco product
CN219982079U (zh) 梗丝加工处理系统
CN105124742B (zh) 一种造纸法再造烟叶萃取液中Cr含量的选择性降低方法
JPS6125473A (ja) たばこの処理方法
DE1517297C (de) Rauchfilter fur Tabakwaren
RU2197877C2 (ru) Фильтр для очистки табачного дыма от вредных веществ
CN105077561A (zh) 一种造纸法再造烟叶萃取液中Cu含量的选择性降低方法
NL8300726A (nl) Het calciumzout van saccharine en de bereiding daarvan.

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): BR DK JP SU